VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
28 hedge funds and large institutions have $213M invested in Verona Pharma in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
56% more funds holding
Funds holding: 18 → 28 (+10)
1.48% more ownership
Funds ownership: 6.74% → 8.22% (+1.5%)
Holders
28
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$31.8M | |
| 2 | +$27.7M | |
| 3 | +$24.3M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$18M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$9.71M |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$410K | |
| 3 | -$303K | |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$184K |
| 5 |
CCFM
Clear Creek Financial Management
Silverdale,
Washington
|
-$175K |